{"nct_id":"NCT05625399","title":"A Study of Subcutaneous Nivolumab + Relatlimab Fixed-dose Combination (FDC) in Previously Untreated Metastatic or Unresectable Melanoma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2023-03-06","start_date_type":"ACTUAL","primary_completion_date":"2025-08-04","primary_completion_date_type":"ACTUAL","completion_date":"2027-11-18","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["BMY"]}